Who owns AEON BIOPHARMA INC?
- Ticker: AEON
- CUSIP Number: 00791x100
Tip: Access positions for across all investors
Analyze quarterly positions in Aeon Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aeon Biopharma stock
Who bought or sold AEON BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Polar Securities | 3.9M | $26M | 100% | Dec 2023 |
|
| Atalaya Capital Management | 3.7M | $23B | 0% | Dec 2023 |
|
| Ikarian Capital | 258k | $1.9M | 0% | Dec 2023 |
|
| Vanguard Group | 210k | $1.5M | 8% | Dec 2023 |
|
| Alyeska Investment Group | 80k | $576k | 100% | Dec 2023 |
|
| BBK Capital Partners | 58k | $419k | -10% | Dec 2023 |
|
| Bank of America Corporation | 23k | $168k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 19k | $134k | -24% | Dec 2023 |
|
| Jpmorgan Chase & Co | 6.9k | $50k | 100% | Dec 2023 |
|
| GHP Investment Advisors | 1.1k | $13k | 0% | Mar 2024 |
|
| UBS Group | 649.00 | $4.7k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 137.00 | $986.002700 | 5% | Dec 2023 |
|
| DuPont Capital Management Corporation | 3.00 | $35.000100 | 0% | Mar 2024 |
|
Who sold out of Aeon Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Sep 2023 | 11k | $59k |